Table 5. Risk of non-chronic problems among respondents with specific chronic diseases.
| Disease | OR (95% CI) | ||||
| mobility | self-care | usual activities | pain and discomfort | anxiety and depression | |
| Infectious disease | |||||
| OR I | 4.1 (1.0–16.4) | 3.7 (0.4–30.9) | 4.7 (1.1–19.2) * | 7.1 (2.8–17.8) ** | 5.9 (2.0–17.0) ** |
| OR II | 0.9 (0.2–3.7) | 0.6 (0.0–6.0) | 0.9 (0.2–3.6) | 1.1 (0.4–2.9) | 1.8 (0.5–5.8) |
| Cancer | |||||
| OR I | 12.7 (4.6–35.2) ** | 18.4 (6.5–52.0) ** | 14.5 (5.9–35.8) ** | 14.1 (7.0–28.5) ** | 10.2 (5.8–18.0) ** |
| OR II | 2.8 (1.0–7.7) | 3.4 (1.2–9.5) * | 2.8 (1.1–6.7) * | 2.2 (1.1–4.3) | 3.2 (2.0–5.0) ** |
| Diabetes | |||||
| OR I | 5.3 (2.8–9.9) ** | 5.6 (2.4–12.9) ** | 8.1 (4.7–14.2) ** | 7.1 (4.1–12.2) ** | 4.8 (2.6–9.1) ** |
| OR II | 1.1 (0.6–2.1) | 1.0 (0.5–2.0) | 1.5 (0.9–2.7) | 1.1 (0.6–1.9) | 1.5 (0.9–2.5) |
| Anemia | |||||
| OR I | 4.8 (1.6–13.7) ** | - | 2.7 (0.7–9.8) | 8.3 (4.5–15.3) ** | 8.3 (4.4–15.5) ** |
| OR II | 1.0 (0.3–3.2) | - | 0.5 (0.1–1.8) | 1.3 (0.7–2.2) | 2.6 (1.3–5.2) ** |
| Mental disease | |||||
| OR I | 9.9 (4.9–20.3) ** | 27.1 (13.7–53.6) ** | 28.6 (16.3–50.0) ** | 16.1 (9.1–28.7) ** | 16.3 (10.8–24.6) ** |
| OR II | 2.2 (1.0–4.6) * | 5.0 (2.4–10.6) ** | 5.4 (3.0–9.9) ** | 2.5 (1.4–4.5) ** | 5.1 (3.0–8.5) ** |
| Heart disease | |||||
| OR I | 10.8 (7.3–16.0) ** | 11.5 (6.5–20.6) ** | 11.1 (7.1–17.3) ** | 10.1 (7.0–14.6) ** | 7.3 (4.8–11.1) ** |
| OR II | 2.4 (1.7–3.4) ** | 2.1 (1.2–3.7) * | 2.1 (1.3–3.3) ** | 1.5 (1.0–2.4) * | 2.3 (1.4–3.7) ** |
| Hypertension | |||||
| OR I | 6.8 (5.0–9.2) ** | 7.7 (4.7–12.5) ** | 6.7 (4.7–9.6) ** | 6.2 (4.6–8.3) ** | 3.7 (2.7–5.2) ** |
| OR II | 1.5 (1.0–2.1) * | 1.4 (0.9–2.0) | 1.3 (0.8–1.9) | 0.9 (0.6–1.3) | 1.1 (0.8–1.6) |
| Cerebrovascular disease | |||||
| OR I | 28.3 (20.7–38.6) ** | 42.2 (28.1–63.6) ** | 31.1 (22.3–43.5) ** | 19.2(14.5–25.6)** | 11.8 (8.7–16.0) ** |
| OR II | 6.3 (4.6–8.5) ** | 7.8 (5.3–11.4) ** | 5.9 (4.0–8.9) ** | 3.0 (2.1–4.2) ** | 3.7 (2.7–5.0) ** |
| Respiratory disease | |||||
| OR I | 6.8 (4.0–11.7) ** | 9.8 (5.2–18.2) ** | 8.6 (4.9–15.0) ** | 8.5 (5.1–14.0) ** | 5.4 (2.9–10.0) ** |
| OR II | 1.5 (0.8–2.7) | 1.8 (0.9–3.4) | 1.6 (0.8–3.1) | 1.3 (0.8–1.9) | 1.6 (0.9–3.0) |
| Digestive disease | |||||
| OR I | 2.7 (1.4–5.0) ** | 4.9 (2.4–10.0) ** | 4.4 (2.0–9.5) ** | 7.0 (4.0–12.1) ** | 3.1 (1.8–5.4) ** |
| OR II | 0.6 (0.2–1.3) | 0.9 (0.3–2.2) | 0.8 (0.3–2.1) | 1.0 (0.6–1.8) | 0.9 (0.6–1.6) |
| Genitourinary disease | |||||
| OR I | 9.0 (5.1–16.1) ** | 7.6 (3.4–16.9) ** | 7.2 (3.4–14.9) ** | 7.2 (3.6–14.4) ** | 4.4 (2.5–7.6) ** |
| OR II | 2.0 (1.0–3.9) * | 1.4 (0.6–2.9) | 1.3 (0.6–3.0) | 1.1 (0.5–2.2) | 1.3 (0.7–2.4) |
| Musculoskeletal disease | |||||
| OR I | 9.5 (6.3–14.3) ** | 8.7 (4.7–16.4) ** | 8.8 (5.4–14.5) ** | 11.1 (7.7–15.8) ** | 5.4 (3.4–8.3) ** |
| OR II | 2.1 (1.5–2.9) ** | 1.6 (0.9–2.6) | 1.7 (1.0–2.7) * | 1.7 (1.3–2.2) ** | 1.6 (1.1–2.5) * |
| Other chronic disease | |||||
| OR I | 7.0 (5.2–9.3) ** | 10.4 (7.2–15.0) ** | 9.1 (6.6–12.6) ** | 9.8 (7.2–13.4) ** | 5.9 (4.7–7.6) ** |
| OR II | 1.5 (1.0–2.2) * | 1.9 (1.2–2.9) ** | 1.7 (1.1–2.6) * | 1.5 (1.1–2.0) ** | 1.8 (1.4–2.4) ** |
Note: OR I = odds ratio of respondents with the selected chronic diseases relative to reference group I as defined in Table 1; OR II = odds ratio of respondents with the selected chronic diseases relative to reference group II as defined in Table 1; *: chi-square test P<0.05; **: chi-square test P<0.01; No marks: not significant.